Effects of allogeneic bone marrow transplantation on pulmonary function in 80 children in a single paediatric centre

B Bruno1, G Souillet, Y Bertrand

  • 1Department of Paediatric Haematology, Debrousse Hospital, Lyon, France. benedicte.bruno@chu-rennes.fr

Insights

Pulmonary function tests after bone marrow transplantation (BMT) show declines in lung capacity. Busulphan conditioning and chronic graft-versus-host disease (GVHD) are linked to worse lung function outcomes in children.

Area of Science:

  • Pediatric Hematology/Oncology
  • Pulmonary Medicine
  • Transplantation Immunology

Background:

  • Allogeneic bone marrow transplantation (BMT) is a curative therapy for various pediatric diseases.
  • Pulmonary complications can significantly impact long-term outcomes post-BMT.
  • Understanding factors influencing pulmonary function is crucial for improving patient care.

Purpose of the Study:

  • To investigate the long-term pulmonary function test (PFT) results in children following allogeneic BMT.
  • To identify associations between PFT abnormalities and conditioning regimens (TBI vs. busulphan) and graft-versus-host disease (GVHD).

Main Methods:

  • Retrospective review of serial PFTs in 80 children undergoing allogeneic BMT over 16 years.
  • Analysis of PFT data in relation to conditioning regimen and cytomegalovirus immune status.
  • Comparison of lung function parameters between different conditioning groups and GVHD status.

Main Results:

  • Significant declines in forced vital capacity (FVC) and forced expiratory volume in 1 second (FEV1) were observed at 2 years post-BMT.
  • Greater reductions in FEV1 and FEV1/FVC ratio were noted in patients conditioned with busulphan compared to total body irradiation (TBI).
  • Patients with chronic GVHD exhibited significantly lower FEV1 and FEV1/FVC ratios, indicating airway obstruction.

Conclusions:

  • Busulphan-based conditioning may be associated with increased long-term lung toxicity compared to TBI.
  • Chronic GVHD is a significant risk factor for developing obstructive airway disease after BMT.
  • These findings warrant consideration of conditioning regimen selection and GVHD management to mitigate pulmonary sequelae.